New guidance on use of infliximab in ulcerative colitis

NICE has issued guidance on the use of infliximab for the treatment of acute exacerbations of ulcerative colitis.

The guidance states that infliximab should only be used in people with acute, severely active ulcerative colitis if treatment with ciclosporin is contraindicated or clinically inappropriate, or if they are taking part in a clinical trial.

A summary of the new guidance is available at  To read the full guidance visit the NICE website.

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in

MIMS Product Slides

Product overviews prepared by the MIMS team, in a handy slide format.

Click here

Slides are initiated, funded & reviewed by the companies specified.

MIMS app

Access the full drug database and quick-reference tables on the go

Find out more